This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization
Scientific Reports Open Access 06 August 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
ORIGINAL RESEARCH PAPER
Byrne, R. A. et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet doi:10.1016/S0140-6736(12)61964-3
Rights and permissions
About this article
Cite this article
Cully, M. Treating restenosis after drug-eluting stent implantation. Nat Rev Cardiol 10, 62 (2013). https://doi.org/10.1038/nrcardio.2012.189
Published:
Issue date:
DOI: https://doi.org/10.1038/nrcardio.2012.189
This article is cited by
-
Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialization
Scientific Reports (2013)